Characteristics of the 264 patients with multidrug-resistant tuberculosis reported from 1992–1999
| Characteristic | Total | Previously treated patient | Patient reported more than once# | ||
| Yes | No | Yes | No | ||
| Total cases | 264 (100) | 174 (100) | 88 (100) | 42 (100) | 222 (100) |
| 15–24 yrs | 20 (7.6) | 12 (6.9) | 8 (9.1) | 3 (7.1) | 17 (7.7) |
| 25–34 yrs | 78 (29.5) | 44 (25.3) | 34 (38.6) | 11 (26.2) | 67 (30.2) |
| 35–44 yrs | 67 (25.4) | 46 (26.4) | 20 (22.7) | 13 (31.0) | 54 (24.3) |
| 45–64 yrs | 61 (23.1) | 44 (25.3) | 16 (18.2) | 12 (28.6) | 49 (22.1) |
| ≥65 yrs | 38 (14.4) | 28 (16.1) | 10 (11.4) | 3 (7.1) | 35 (15.8) |
| Male | 184 (69.7) | 128 (73.6) | 54 (61.4) | 26 (61.9) | 158 (71.2) |
| Female | 80 (30.3) | 46 (26.4) | 34 (38.6) | 16 (38.1) | 64 (28.8) |
| Country of birth | |||||
| France | 115 (43.6) | 76 (43.7) | 39 (44.3) | 14 (33.3) | 101 (45.5) |
| Other country | 147 (55.7) | 96 (55.2) | 49 (55.7) | 28 (66.7) | 119 (53.6) |
| Unknown | 2 (0.8) | 2 (1.1) | 0 (0.0) | 0 (0.0) | 2 (0.9) |
| Place of residence | |||||
| France | 218 (82.6) | 142 (81.6) | 76 (86.4) | 36 (85.7) | 182 (82.0) |
| Other country | 45 (17.0) | 31 (17.8) | 12 (13.6) | 6 (14.3) | 39 (17.5) |
| Unknown | 1 (0.4) | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.5) |
| HIV‐positive | 55 (20.8) | 29 (16.7) | 24 (27.3) | 5 (11.9) | 50 (22.5) |
| HIV‐negative | 169 (62.9) | 114 (65.5) | 55 (62.5) | 33 (78.6) | 136 (61.3) |
| HIV unknown | 40 (16.3) | 31 (17.8) | 9 (10.2) | 4 (9.5) | 36 (16.2) |
| Site of disease | |||||
| Pulmonary | 207 (78.4) | 144 (82.8) | 61 (69.3) | 36 (85.7) | 171 (77.0) |
| Extrapulmonary | 19 (7.2) | 10 (5.7) | 9 (10.2) | 5 (11.9) | 33 (14.9) |
| Both | 38 (14.4) | 20 (11.5) | 18 (20.5) | 1 (2.4) | 18 (8.1) |
| Microscopy | |||||
| Positive | 156 (59.1) | 110 (63.2) | 45 (51.1) | 29 (69.0) | 127 (57.2) |
| Negative | 94 (35.6) | 52 (29.9) | 41 (46.6) | 10 (23.8) | 84 (37.8) |
| Unknown | 14 (5.3) | 12 (6.9) | 2 (2.3) | 3 (7.1) | 11 (5.0) |
| Resistance to other first‐line drugs | |||||
| None | 100 (37.9) | 70 (40.2) | 30 (34.1) | 15 (35.7) | 85 (38.3) |
| SM alone | 78 (29.5) | 50 (28.7) | 28 (31.8) | 10 (23.8) | 68 (30.6) |
| EMB alone | 18 (6.8) | 10 (5.7) | 8 (9.1) | 4 (9.5) | 14 (6.3) |
| SM and EMB | 68 (25.8) | 44 (25.3) | 22 (25.0) | 13 (31.0) | 55 (24.8) |
Data are presented as n (%)
#: patient reported more than once (at least for 2 yrs) during the 1994–1998 period
All information were missing for one case in 1999 and two cases had no information on history of treatment
HIV: human immunodeficiency virus
SM: streptomycin
EMB: ethambutol